How Many Units of Botox for TMJ Are Needed?

Most practitioners inject between 20 and 50 units of Botox (onabotulinumtoxinA) into each masseter muscle for TMJ-related pain and dysfunction, with additional units going into the temporalis or other jaw muscles depending on the specific problem. That puts a typical total session somewhere in the range of 40 to 200 units spread across multiple sites. The wide range exists because TMJ disorders are not one condition but a cluster of problems involving different muscles, joints, and habits, and the dose that works depends heavily on which muscles are involved, how large they are, and what symptom you are trying to control.

What Most People Get in the Masseter

The masseter, the thick muscle you can feel bulging at the angle of your jaw when you clench, is the most commonly injected site for TMJ treatment. A survey of clinicians who offer botulinum toxin for TMJ-related myalgia found that the masseter was the most frequently targeted muscle group, with Botox doses ranging from 30 to 100 units per muscle.¹ Since both sides are typically treated, that means a masseter-only session could involve anywhere from 60 to 200 units total. The lower end is more common for someone with a smaller jaw or milder clenching habit, while higher doses tend to be reserved for people with visibly enlarged masseters from chronic bruxism or severe muscle hyperactivity.

Practitioners often start conservatively and increase the dose at follow-up if the initial amount did not provide enough relief. A starting dose of 25 to 30 units per side is common for a first-time patient, with adjustments made based on how much the pain and clenching improve over the following weeks.

Dosing the Temporalis and Lateral Pterygoid

TMJ problems do not always center on the masseter alone. The temporalis, the fan-shaped muscle running along the side of your head above the ear, is frequently involved in jaw clenching and tension headaches. Early clinical work on botulinum toxin for TMJ disorders used 25 units per temporalis muscle, injected alongside the masseter treatment.² That dose has remained a reasonable starting point in practice, though some clinicians go higher for patients with pronounced temporalis bulk or persistent headache patterns.

The lateral pterygoid muscle is a deeper, harder-to-reach muscle that controls forward and side-to-side jaw movement. When it is the primary source of dysfunction, as in chronic jaw dislocation or disc displacement, it gets its own injection. Published protocols have used doses in the range of 15 to 30 units per side for this muscle. One study of patients with chronic TMJ dislocation used 15 to 25 units adjusted for the patient’s age and estimated muscle volume.³ Another protocol for anterior disc displacement used 30 units injected under ultrasound guidance.⁴ Because this muscle sits deep behind the jawbone, accurate placement matters more than with the masseter, and some practitioners use ultrasound or navigation-guided imaging to ensure the toxin reaches the right spot.

Lateral pterygoid injections showed promising results in a study of persistent myogenic TMJ pain, where patients experienced a roughly 65 percent reduction in pain intensity at one month and about 49 percent at three months, with peak effectiveness at the one-month mark.⁵

Why the Brand Changes the Number

If your provider quotes you a number that sounds much higher or lower than you expected, the brand of neurotoxin may be the reason. “Units” are not universal across brands. One unit of Botox (onabotulinumtoxinA) is not the same as one unit of Dysport (abobotulinumtoxinA). Dysport units are roughly two to three times the numerical value of Botox units for a comparable clinical effect, which is why Dysport doses for the masseter ranged from 50 to 300 units per muscle in the same survey where Botox doses ranged from 30 to 100.¹ Xeomin (incobotulinumtoxinA) units are generally considered comparable one-to-one with Botox, though individual response can vary.

This distinction matters when you are comparing notes with someone else who got “Botox for TMJ” or reading about doses online. A person who received 120 units of Dysport per side is not getting three times the treatment of someone who got 40 units of Botox per side. They are in roughly the same ballpark. Always ask which product is being used before comparing numbers.

How Well Does It Actually Work?

The evidence on botulinum toxin for TMJ disorders is real but messier than many providers let on. Individual studies have reported encouraging results. One uncontrolled pilot study found that 85 percent of patients had improved pain on mouth opening and 90 percent showed improvement in pain during chewing.⁶ Numbers like that look impressive, but uncontrolled studies cannot separate the drug’s effect from the placebo response, and TMJ symptoms are highly responsive to placebo.

When researchers pooled the available controlled trials, the picture became more ambiguous. A systematic review and meta-analysis found no significant difference between botulinum toxin and placebo or other treatments for maximum mouth opening, bruxism events, or maximum bite force.⁷ That does not mean Botox is useless for TMJ. It means the evidence is not as strong as many clinics suggest, and the benefit for pain may partly reflect how the treatment feels rather than a clean pharmacological victory over placebo. For many patients the pain relief is genuine and meaningful regardless of how much of it is placebo-mediated, but you should know the state of the science before investing in repeated rounds of injections.

What to Expect After the Injection

Botulinum toxin does not work instantly. Most people begin to notice changes within a few days to two weeks, as the toxin gradually blocks the nerve signals that tell the muscle to contract. Peak effect typically arrives around four to six weeks, and the benefit lasts roughly three to four months before the muscle starts regaining its normal activity. Research on facial volume changes after masseter injections found the greatest reduction at 12 weeks, which aligns with when muscle relaxation is at its strongest.⁸

Because the effect wears off, most people who respond well end up on a cycle of repeat injections roughly every three to six months. Some providers report that the interval between sessions can gradually lengthen as the muscles are “retrained” to a lower baseline of activity, though this is more clinical observation than established fact.

The Bone Density Question

One concern that rarely comes up in a consultation but deserves attention is the effect of repeated masseter injections on jawbone density. When a muscle stops contracting against bone, the bone underneath gradually remodels in response to the reduced mechanical load. This is the same principle behind bone loss in astronauts or in a limb that has been immobilized in a cast.

A systematic review and meta-analysis on this topic found that in humans, botulinum toxin injection into the masticatory muscles led to about a 6 percent decrease in cortical thickness of mandibular regions, though no clear changes were detected in bone volume or density overall.⁹ Animal studies have shown more dramatic effects, with significant bone loss at the condyle, the rounded part of the jawbone that sits inside the TMJ itself.¹⁰

The effect appears to be more pronounced in certain populations. A study of female adults found that cortical bone quality at the muscle attachment sites and at the TMJ condyles was reduced after injections, and these effects were greater in postmenopausal women than in younger women.¹¹ For someone getting one or two rounds of Botox to break a severe clenching cycle, this is probably not a meaningful concern. For someone contemplating years of regular injections, especially postmenopausal women already at elevated risk for bone loss, it is worth discussing with both your injector and your dentist.

When Botox Stops Working

A small percentage of patients find that Botox becomes less effective over time. The most well-documented reason is the development of neutralizing antibodies against the toxin. Your immune system can learn to recognize the botulinum toxin protein and mount an antibody response that blocks it before it reaches the nerve terminal. In a study of patients receiving botulinum toxin for dystonia, all patients who tested positive for antibodies had failed to respond to injections on at least two consecutive sessions, and compared to antibody-negative patients, they had received higher average doses per visit and higher total cumulative doses.¹²

A review of causes of treatment failure confirmed the pattern: larger doses per treatment, higher overall cumulative doses, and a high frequency of treatments were all associated with an increased risk of developing these neutralizing antibodies.¹³ This creates a practical tension. The muscles involved in TMJ problems tend to require higher doses than cosmetic applications, and people use the treatment repeatedly over long periods. Using the lowest effective dose and spacing sessions as far apart as possible is one strategy to reduce this risk. Switching to a different brand of neurotoxin can sometimes help, since the antibodies may not cross-react fully with a different formulation.

Botox Versus Bite Splints

Many people considering Botox for TMJ have already tried a bite splint, or their dentist is recommending one instead. A systematic review and meta-analysis that directly compared occlusal splints with botulinum toxin for managing the clinical effects of sleep bruxism found that both reduced pain-related symptoms, with no statistically significant difference between the two at intermediate follow-up. Some individual studies within the review noted faster short-term relief with Botox, but over time the outcomes converged.¹⁴

The practical tradeoffs are straightforward. A bite splint is a one-time cost that does not wear off, does not involve needles, and carries no risk of bone density changes or antibody development. It can, however, be uncomfortable, easy to stop wearing, and ineffective for daytime clenching. Botox works whether you remember to use it or not, acts directly on muscle overactivity rather than just cushioning the teeth, and provides relief that some people describe as transformative. But it is expensive over time, requires repeated office visits, and the concerns about long-term bone effects have not been fully resolved. Many practitioners ultimately recommend both, using a splint at night and Botox to bring down the baseline muscle tension during the day.

The Facial Slimming Effect

One consequence of masseter Botox that some people consider a benefit and others find unwelcome is a visible narrowing of the lower face. When the masseter is weakened, it shrinks over the following weeks, and the jawline becomes slimmer. This is the same mechanism used in cosmetic “masseter reduction” or “jaw slimming” procedures, just applied for a medical reason.

A dose-finding study tested several Botox dose levels for masseter reduction and found that all groups showed significant reduction in masseter thickness by 12 weeks compared to placebo, with a clear dose-dependent relationship. The lowest dose tested, 24 units per side, did produce measurable thinning but was considered potentially insufficient for resolving a visibly square jawline.¹⁵ A study using abobotulinumtoxinA (Dysport) at 90 units per side for masseter hypertrophy found that the maximum facial slimming effect occurred at 12 weeks, with an average reduction of about 12 percent in the lower third of the face at that time point.¹⁶

If you are getting masseter Botox for TMJ and you enjoy the look of a broader or more angular jawline, this is worth knowing in advance. The slimming is temporary and reverses as the muscle regains its size, but at therapeutic doses for TMJ it is often noticeable enough that friends or family may comment on it. Conversely, if jaw slimming is something you want, treating TMJ and achieving a cosmetic result with the same injection is a genuine two-for-one.

Factors That Influence Your Specific Dose

The reason no article can give you a single number is that the right dose depends on several overlapping variables that your provider evaluates in person:

Muscle size: People with larger, more developed masseters from years of clenching or natural anatomy need higher doses. A petite person who grinds mildly at night and a powerlifter who clenches through workouts are not getting the same injection.
Which muscles are involved: Masseter-only treatment uses fewer total units than a protocol that also targets the temporalis, lateral pterygoid, or medial pterygoid.
Symptom severity: Someone with constant pain and locked-jaw episodes may start at a higher dose than someone with mild soreness on waking.
Brand of toxin: As covered earlier, Dysport numbers are roughly two to three times the Botox numbers for the same clinical effect.
Treatment history: First-time patients often receive a conservative dose to gauge response. Subsequent sessions are adjusted up or down based on how much relief the previous round provided and how quickly it wore off.

A reasonable expectation for a first session targeting both masseters with onabotulinumtoxinA is somewhere around 25 to 50 units per side, with an additional 20 to 25 units per side if the temporalis is also being treated. Those numbers can shift substantially in either direction. The goal is the minimum effective dose that gives you meaningful symptom relief, because using more than necessary increases cost and, over the long run, raises the risk of both bone thinning and antibody development.